International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, ...

The Department of Homeland Security is asking for the Internal Revenue Service to help crack down on immigration, according ...

Change your smartphone wallpaper, and suddenly, you’ll feel like you’re holding a whole new device. Changing the wallpaper on your Android is also a straightforward task. What’s hard is ...

These free online tools let you skip the setup and start tracking your money right away. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

2 Hilton Court: A 113,000-square foot office building last occupied by Daiichi Sankyo in 2016 was demolished last year to ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

Here’s how it works. My team and I compared the best office desks for the office and home, looking at everything from build quality and stability to extra storage and the productivity benefits ...

GSK (GSK), a large British drug maker, is rallying 8% after reporting higher-than-expected fourth-quarter earnings per share and raising its long-term revenue guidance. Last quarter, its operating ...

Banco Santander topped Stoxx 600 gains, up 8.3%, after the Spanish lender reported record quarterly profit. Pharma giant GSK closed 7.6% higher after hiking its long-term sales guidance and posting ...

GSK said it now e American depositary shares of GSK jumped more than 8% Wednesday after the drugmaker reported better-than-expected quarterly results and boosted its long-term sales forecast.

This is not just a simple background that you just throw on as wallpaper. It’s a Windows 11 modern skin pack that will also change your icons, the taskbar, buttons, and windows. Every Unix-based OS is ...

Before leaving office, President Biden’s health secretary ... adults who get the new RSV vaccines marketed by Pfizer and GSK may be at a slightly higher risk of developing Guillain-Barré ...